|Budget Amount *help
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2012: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Brain natriuretic peptide (BNP) is a clinical useful marker forheart failure. In the present study, we observed the significant association between plasma BNP levels and electrocardiographic left ventricular hypertrophy. However, we did not find the significant association between electrocardiographic left ventricular hypertrophy and the NPPB genotype. Furthermore, we did not find any significant association between the NPPB genotype and future cardiovascular disease risk. Therefore, it is needed for further research to examine the association between CVD risk and the NPPB genotype.